Naming a successor and evidencing that the named successor is ready to step into the role within twelve months are two structurally different governance obligations — and most boards have been discharging only the first.
In Brief
- Naming a successor and evidencing their readiness are two different governance obligations — most boards have discharged only the first.
- Succession risk concentrates at Director and VP+ level, where readiness is least evidenced and transitions occur most often.
- AI-driven role compression has disrupted the pipeline that produced successor readiness, removing the development pathway succession plans relied on.
- AICD has signalled that boards may face negligence exposure for failure to invest in leadership capability development.
- The governance question is no longer whether a succession plan exists, but whether the readiness behind it can be evidenced.
Performance does not evidence readiness
At CEO level, succession governance is comprehensive — a board-level process with visible investment in candidate preparation, scenario planning, and development pathways. At Director and Vice President+ (VP+) level, where leadership transitions occur most frequently and where strategy is most directly translated into execution, that investment is far less visible and far less evidenced. Pinsight’s 2026 research confirms what governance professionals have been observing: performance in a current role is a weak predictor of success at the next level, and the capabilities required at Director and VP+ are fundamentally different from those that produced the track record (Pinsight, 2026). Succession risk concentrates precisely where readiness visibility is lowest.
That risk pattern reflects an assumption boards have held for decades: that the organisational pipeline would, over time, produce Director and VP+ candidates whose readiness could be inferred from their track record. The candidate had been through the roles and demonstrated performance; the pipeline had done its work.
The same structural principle applies in clinical medicine: a doctor’s performance in their current speciality does not evidence readiness at consultant level, because the credentialing process requires demonstrated competency in conditions specific to the senior appointment. Past performance in a different context does not produce evidence of readiness for a qualitatively different role.
The assumption holds when mid-level leadership development roles are staffed and functioning: the positions where future senior leaders develop the ability to operate cross-functionally, manage complexity without full authority, and hold direction under constraint. These capabilities are not built through formal training programs. They are built through accumulated experience in the roles that require them.
AI-driven role compression has disrupted that pathway, eliminating or fundamentally reshaping the mid-level positions where leadership capability was developed. The implication is not simply that fewer people now occupy those roles. It is that the mechanism through which boards could reasonably assume a named successor was ready has been removed.
The mechanism through which boards could reasonably assume a named successor was ready has been removed.
The named successor may have performed well in their current role and hold genuine strategic credibility. But the organisation can no longer rely on the pathway that would have produced the observable evidence of their readiness, because that pathway has changed beneath the succession plan.
The exposure is already on record
The Australian Institute of Company Directors (AICD) has signalled that boards may face negligence exposure for failure to invest in leadership capability development, not for naming an unprepared successor in good faith but for the structural failure to discharge the obligation to create and evidence the conditions under which readiness develops (AICD).
That signal shifts the governance question materially. The board that names a successor and cannot evidence the investment in their development is potentially exposed on duty of care.
The exposure builds with each succession cycle. The Director designated as successor three years ago, who came through a pipeline that has since been disrupted, is not necessarily better prepared today, and the board’s capacity to demonstrate that preparation has not improved. Each time the board reviews the succession plan, approves the same names, and returns the same governance sign-off without an evidence base behind it, what it asserts diverges further from what it can demonstrate.
When a succession event occurs, whether planned or forced, the question asked of the board will not be whether a name was recorded, but whether reasonable steps were taken to ensure that person was prepared. The AICD signal suggests that “we had a succession plan” will not, under current governance expectations, be a sufficient answer.
The question your plan doesn't answer
Separating the designation question from the evidence question does not require rebuilding the succession plan. What needs to change is the board’s capacity to answer a harder question: what evidence do we have that this person is ready, and how was that evidence generated?
That question requires boards to examine the targeted investment in conditions that would produce a Director or VP+ capable of stepping into the role in the next twelve months if called upon. Where that investment does not exist, the succession plan records an aspiration, not a readiness assessment.
The boards that are ahead of this shift have already separated the designation question from the evidence question. The designation (who is named as successor) is a governance record. The evidence question (what the organisation knows about their readiness, and what investment has been made to develop and test it) is the governance obligation the AICD signal is describing. Those two questions require different conversations with management, different disclosures to the governance committee, and different documentation standards.
What this means for senior leaders: A succession plan that records names and a succession governance process that evidences readiness are not the same document, and most organisations have built the first without investing in what the second requires. The board that cannot answer the evidence question when it is asked is holding a governance exposure its succession plan does not cover.
The board that can evidence the readiness of its named successors occupies a governance position its peers cannot yet hold — not because it has a better succession plan on record, but because it separated the designation question from the evidence question before a succession event required the distinction.
References
- Pinsight. (2026). Five defining trends reshaping succession planning in 2026. Pinsight. https://www.pinsight.com/resources/five-defining-trends-reshaping-succession-planning-in-2026/
